(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate CAS:866607-35-4

The compound (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate has shown promise in various pharmaceutical applications.   Its unique structure and properties make it a potential candidate for drug development.   Specifically, it has demonstrated potential in the following areas: Anticancer Research: Studies have shown that this compound exhibits inhibitory effects on specific cancer cell lines, suggesting its potential as an anticancer agent.   Further research is being conducted to explore its mechanism of action and potential application in cancer therapy. Anti-inflammatory Properties: Preclinical studies have indicated that (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate may possess anti-inflammatory properties.   This has sparked interest in investigating its potential for treating inflammatory conditions. Neurological Disorder Research: Initial studies suggest that this compound could have implications for neurological disorders.   Its interactions with specific neuronal pathways have prompted further investigation into its potential use in neurology and psychiatry. Drug Delivery Systems: The unique structural features of (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate make it a candidate for developing novel drug delivery systems.   Its ability to encapsulate and release other molecules has attracted interest in targeted drug delivery applications. In conclusion, the compound (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyltriacetate holds potential in diverse pharmaceutical applications, ranging from cancer therapy to drug delivery systems, making it a subject of ongoing research and development.